TCL Archive Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber. April 14, 2006
TCL Archive Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention January 21, 2011
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012